SCHEMBL5323909

SCHEMBL5323909

Oc1cccc(CCN2CCOCC2)c1O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.54
CYP2C9 P11712 2/20 0.49
ALOX15 P16050 1/20 0.49
HSD17B10 Q99714 1/20 0.49
KMT2A Q03164 4/20 0.47
MEN1 O00255 1/20 0.47
KDM4E B2RXH2 3/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
LMNA P02545 2/20 0.45
GAA P10253 2/20 0.45
MPI P34949 1/20 0.45
HTT P42858 1/20 0.45
RECQL P46063 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
KDM4C Q9H3R0 1/20 0.45
SIGMAR1 Q99720 2/20 0.45
POLB P06746 1/20 0.45
HTR2A P28223 2/20 0.43
HTR2C P28335 1/20 0.43
HTR2B P41595 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10454920 0.87 HRH3 (0.72) HRH3CYP2C9ALOX15HSD17B10KMT2A
SCHEMBL5323114 0.81 KMT2A (0.49) HRH3CYP2C9ALOX15HSD17B10KMT2A
SCHEMBL23964430 0.81 MAPT (0.49) HRH3CYP2C9ALOX15HSD17B10KMT2A
SCHEMBL23964432 0.81 MEN1 (0.49) HRH3CYP2C9ALOX15HSD17B10KMT2A
SCHEMBL23926340 0.81 ERN1 (0.46) HRH3CYP2C9ALOX15HSD17B10KMT2A
SCHEMBL2799254 0.81 HRH3 (0.54) HRH3LMNASIGMAR1HTR2AHTR2C
SCHEMBL23926333 0.77 SIGMAR1 (0.61) HRH3KMT2AMEN1KDM4EHTT
SCHEMBL738862 0.77 SIGMAR1 (0.47) HRH3L3MBTL1SIGMAR1POLBCYP2A13
SCHEMBL24127975 0.76 POLB (0.51) CYP2C9ALOX15HSD17B10KMT2AMEN1
SCHEMBL4425954 0.75 SIGMAR1 (0.53) HRH3KMT2AMEN1L3MBTL1SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007114672-A1 AGENT FOR THE PREVENTION AND TREATMENT OF METABOLIC BONE DISEASE BY ENHANCING OSTEOPROTEGERIN SECRETION OSCOTEC INC. (KR) 2007-10-11 WO disclosed